Company: JUNS
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-010990
Chunk: 14

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Item 1
Chunk 14
---
 of common stock, 1,162,500
ratably  to each entity with an aggregate fair value at issuance totaling $4,638,375 which were registered upon the closing
of the IPO in December 2024. In addition, each of the entities agreed to and ultimately purchased 37,500 shares
of the Company’s common stock at a purchase price of $1.33 per
share prior to the effective date of the IPO, resulting in aggregate proceeds of $150,000.

Pursuant to the agreements, the
counterparties are obligated to perform certain services, as defined, and the Company is recognizing the fair value of the issued
restricted shares as compensation expense over the 36-month term, the requisite service period. As of
March 31, 2025 and December 31, 2024, the Company recorded compensation expense of $381,233
and $893,781,
respectively, related to the restricted shares issued.

    17

JUPITER NEUROSCIENCES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2025

Note 6 – Stockholders’ Equity,
continued

Stock Options

The Company grants stock awards to officers,
employees, directors, and other key persons pursuant to its 2021 Equity Incentive Plan (“the Plan”).

In January 2024, the Company granted 180,000
stock options to a consultant with an exercise price of $1.33
per share and a grant date fair value of $190,560, of which 50% vested immediately with the remaining 50% being vested over a 12 month period.

As discussed in Note 3 – Related Party
Transactions, the Company also issued options for the forgiveness of accrued compensation.

The grant date fair value of stock options issued during the three-month period ended March 31, 2024 was determined using the Black-Scholes
Option Pricing Model. The significant inputs were as follows:

Schedule
of Grant Date Fair Value of Stock Options Issued

    Dividend Yield 
     0%
  
    Weighted average expected term (years) 
     6 
  
    Volatility 
     97.3%
  
    Risk-free rate 
     4.10%
  
    Weighted average exercise price 
    $1.33 

    18

JUPITER NEUROSCIENCES, INC.

NOTES TO COND